❤️ 7 years, thousands of hearts, one insight! ADVANCE-DK shows CT-FFR from coronary CT angiography predicts long-term cardiovascular risk. Non-invasive, reliable, and game-changing for patient care! #Cardiology#Radiology
https://t.co/4jiTfPcpHc
Long-term outcomes from the ADVANCE-DK Registry presented at TCT 2024 confirm the use of HeartFlow’s AI-enabled FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease.
Read more about the positive seven-year data from ADVANCE-DK and a new study validating lesion-specific FFRCT in patients with NSTE-ACS here: https://t.co/uj8egsFwYT.
#cCTA#CoronaryPhysiology#Plaque
ADVANCE-DK:
F F R - C T
to exclude hemodynamically
significant lesions
in high-risk NSTE - A C S
PUBLICATION::
👇
https://t.co/s4YfM5PiON
👋 @KTaekker 🇩🇰
We’re 7 days away from the start of #TCT2024!
Don’t forget to stop by an exciting HeartFlow data session happening on Sunday, October 27 at 8AM EST in Presentation Theater 3. We’ll be with Dr. Kristian Taekker Madsen discussing a 7-year follow up of the ADVANCE-DK Registry.
Come connect with us: https://t.co/SicLdFsylR.
#HeartFlow #CAD #yesCCT #FFRCT
#CoronaryPhysiology#CCTA
O U T C O M E S &
Completeness of Revascularization
by F F R c t
in stable angina
Incomplete revasc with
abnormal FFRCT ➡️
⬆️risk of
CV death, non-fatal MI
👇
https://t.co/u1xWla6yDO
👋 @ktaekker@fairbairn_tim#AdvanceDK
Our team had an amazing time at #ICNCCT2024 in Seville, hosting a Symposium on CCTA+FFRCT.
Dr. Kristian Madsen shared insights from the ADVANCE-DK study, Dr. Gianluca Pontone reviewed evidence for HeartFlow FFRCT, and Dr. Carlos Collet discussed its role in intervention planning.
@escardio@KTaekker@ColletCarlos@gpontone1 #FFRCT
HeartFlow ist für die Deutschen Kardiodiagnostik-Tage in Leipzig!
Symposium zu CCTA + FFRct: Ein neuer Weg der Versorgung. Mit Paul Martin Bansmann, @pajhaworth, @KTaekker. Verpassen Sie nicht diese Veranstaltung zur
modernsten Herzversorgung @DRG_de
FFR-CT may identify patients with stable coronary artery disease at risk of long-term recurrent angina.
This could help clinicians in personalizing antianginal treatment.
https://t.co/mWby0ZqGUT
#stablecoronaryarterydisease#stableangina#HeartFlow
Dr. Kristian Madsen and I discuss the 3-year outcomes from ADVANCE DK
Plaque volume and FFRCT are not correlated and offer independent prognostic information
#snackablehealth s/b HeartFlow
Coronary CTA–derived fractional flow reserve value >0.80 was associated with reduced risk of adverse 3-year outcome in participants with stable angina and in those with high coronary artery calcium score. @KTaekker https://t.co/BkpJDxBUY6
#FFRCT provides prognostic information on 3-year risk of cardiovascular death or spontaneous MI also in patients with high #coronaryarterycalcification
https://t.co/6LS8k4HyVy
#FFR-CT may be a useful tool for clinicians in terms of identifying patients who are at risk of experiencing recurrent #angina following standard-of-care therapy.
https://t.co/O3sUHi4y6b